Skip to main
BCPC

Balchem (BCPC) Stock Forecast & Price Target

Balchem (BCPC) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Balchem Corp is projecting an increase in GAAP earnings per diluted share, expecting $4.73 in 2025 and $5.17 in 2026, reflecting strong growth anticipated from the Human Nutrition and Health segment. In addition, the company's financial results for the second quarter of 2025 showed revenues of $255.5 million, which exceeded estimates and marked a 1% increase from the previous year, indicating consistent performance. Furthermore, with expectations for improving gross and net margins, along with a potential debt-free status by the end of next year, Balchem is well-positioned for future growth and possible accretive mergers and acquisitions due to its robust balance sheet.

Bears say

Balchem Corp's financial outlook appears negative due to several key factors, including a decline in the applicable P/E multiple from 39.6x to 37.9x, suggesting investor caution as share prices and revenue multiples of comparable companies have weakened. The company's animal health and nutrition segment reported third-quarter sales of $56.4 million, falling short of the $60 million estimate, while the industrial products segment also missed expectations with revenues of $1.4 million against a forecast of $1.6 million. Additionally, significant risks, such as anticipated slower growth in core business segments, inflationary pressures, and potential disruptions to the European operations, further heighten concerns about Balchem's future performance and market positioning.

Balchem (BCPC) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Balchem and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Balchem (BCPC) Forecast

Analysts have given Balchem (BCPC) a Buy based on their latest research and market trends.

According to 2 analysts, Balchem (BCPC) has a Buy consensus rating as of Dec 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $176, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $176, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Balchem (BCPC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.